Géraldine Falgarone
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Géraldine Falgarone has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
Marie-Christophe Boissier
3 shared publicationsSandrine Rullé
Sorbonne Paris Cité, Université Paris 13, Bobigny, France
3 shared publicationsMarie‐Christophe Boissier
Sorbonne Paris Cité, Université Paris 13, Bobigny, France
2 shared publicationsAbdellatif Essabbani
Institut National de la Santé et de la Recherche Médicale (INSERM), U1016, Institut Cochin, Département d'Immunologie-Hématologie
1 shared publicationAbokouo Zago
INSERM ERI18, Paris 13 University, AP‐HP Rheumatology Department, Avicenne Hospital, Bobigny, France
1 shared publicationCarine Asensio
INSERM UMR-S, hôpital Lariboisière, Paris, France
1 shared publication
Latest Publications
- 1 October 2012
- Published by Elsevier in Joint Bone Spine
- Vol. 79 (5) , 437-440
B-cell targeted treatments for lupus: The journey counts as much as the destination
- 1 October 2012
- Published by Elsevier in Joint Bone Spine
- Vol. 79 (5) , 437-440
B-cell targeted treatments for lupus: The journey counts as much as the destination
- Open Access
- 20 February 2012
- Published by Wiley in Immunology
- Vol. 136 (2) , 252-264
Adrenomedullin, a neuropeptide with immunoregulatory properties induces semi‐mature tolerogenic dendritic cells
Summary: Dendritic cells (DC) play a pivotal role in tolerance. Adrenomedullin (AM), a neuropeptide with anti‐apoptotic and anti‐inflammatory effects, may decrease T helper type 1 effector cells and induce regulatory T (Treg) cells. The aim of this study was to evaluate AM effects on murine dendritic cell (DC) maturation and functions. Bone marrow‐derived DC were produced and stimulated with CpG motifs, lipopolysaccharide or AM for 24 hr. Then, DC maturation and expression of AM and AM receptors were evaluated. Compared with lipopolysaccharide‐stimulated or CpG‐stimulated DC, AM‐stimulated DC had lower levels of co‐stimulatory molecule expression and pro‐inflammatory cytokine release. The AM induced high levels of interferon‐γ but not of interleukin‐10. Importantly, AM inhibited lipopolysaccharide‐induced maturation of DC. However, allogeneic T‐cell stimulation and endocytic capacity of AM‐stimulated DC were comparable to those of semi‐mature and mature DC. Moreover, DC expressed AM and its receptors at a basal level, and AM receptor expression increased with DC maturation. The AM stimulation induced indoleamine 2,3‐dioxygenase (IDO) expression, promoting Treg cell expansion. For the first time, we describe the DC maturation phenotype by a neuropeptide (AM). We have demonstrated that AM and its receptors are expressed in DC and that exogenous AM can modify the DC phenotype and functions and can induce a semi‐mature DC phenotype with IDO expression. These results indicate close interactions among immune system regulation mechanisms and calcitonin‐like peptides.
- 20 February 2012
- Published by Wiley in Immunology
- Vol. 136 (2) , 252-264
Open AccessAdrenomedullin, a neuropeptide with immunoregulatory properties induces semi‐mature tolerogenic dendritic cells
Summary: Dendritic cells (DC) play a pivotal role in tolerance. Adrenomedullin (AM), a neuropeptide with anti‐apoptotic and anti‐inflammatory effects, may decrease T helper type 1 effector cells and induce regulatory T (Treg) cells. The aim of this study was to evaluate AM effects on murine dendritic cell (DC) maturation and functions. Bone marrow‐derived DC were produced and stimulated with CpG motifs, lipopolysaccharide or AM for 24 hr. Then, DC maturation and expression of AM and AM receptors were evaluated. Compared with lipopolysaccharide‐stimulated or CpG‐stimulated DC, AM‐stimulated DC had lower levels of co‐stimulatory molecule expression and pro‐inflammatory cytokine release. The AM induced high levels of interferon‐γ but not of interleukin‐10. Importantly, AM inhibited lipopolysaccharide‐induced maturation of DC. However, allogeneic T‐cell stimulation and endocytic capacity of AM‐stimulated DC were comparable to those of semi‐mature and mature DC. Moreover, DC expressed AM and its receptors at a basal level, and AM receptor expression increased with DC maturation. The AM stimulation induced indoleamine 2,3‐dioxygenase (IDO) expression, promoting Treg cell expansion. For the first time, we describe the DC maturation phenotype by a neuropeptide (AM). We have demonstrated that AM and its receptors are expressed in DC and that exogenous AM can modify the DC phenotype and functions and can induce a semi‐mature DC phenotype with IDO expression. These results indicate close interactions among immune system regulation mechanisms and calcitonin‐like peptides.
- 1 February 2012
- Published by American Physiological Society in Physiological Genomics
- Vol. 44 (3) , 229-235
Implication of clusterin in TNF-α response of rheumatoid synovitis: lesson from in vitro knock-down of clusterin in human synovial fibroblast cells
Recently clusterin (CLU) was reported to be an inhibitor of NF-κB pathway and involved in rheumatoid arthritis (RA) synovitis. This study was designed to decipher the molecular network linked to CLU expression in FLS (fibroblast-like synoviocytes) and evaluate the consequences of its low expression in conditions of TNF-α stimulation. FLS were transfected with siRNA for CLU or not and cultured for 24 and 48 h with TNF-α or not. Pan-genomic gene expression was assayed by DNA microarray. The gene network around CLU and gene interactions were analyzed with the Ingenuity Pathway Analysis software. Downregulation of CLU resulted in modification of the expression of genes known to be directly linked to CLU and for almost 5% of the tested genes (857 out of 17,225); the upregulation of a small group of gene (e.g., TIAM1) emphasizes the hypothetical role of CLU in the pseudotumoral characteristic of FLS. The comparison of gene expression with or without TNF stimulation allowed the classification of sampled with good concordance. Moreover, differential comparison showed that CLU downregulation in RA led to a profound modification of the TNF-α response as three sets of genes emerged: 497 genes modulated by siCLU transfection with TNF stimulation, 356 genes modified because of TNF stimulation only, and 484 genes modulated during TNF stimulation with CLU expression (e.g., IL-8 and Wnt signaling genes). Using a global two-way ANOVA we could identify a set of genes defining a molecular signature of TNF response directly influenced by CLU. These results (based on differential gene expression patterns) argue that CLU downregulation in FLS alters their aggressiveness in RA synovitis.
- 1 February 2012
- Published by American Physiological Society in Physiological Genomics
- Vol. 44 (3) , 229-235
Implication of clusterin in TNF-α response of rheumatoid synovitis: lesson from in vitro knock-down of clusterin in human synovial fibroblast cells
Recently clusterin (CLU) was reported to be an inhibitor of NF-κB pathway and involved in rheumatoid arthritis (RA) synovitis. This study was designed to decipher the molecular network linked to CLU expression in FLS (fibroblast-like synoviocytes) and evaluate the consequences of its low expression in conditions of TNF-α stimulation. FLS were transfected with siRNA for CLU or not and cultured for 24 and 48 h with TNF-α or not. Pan-genomic gene expression was assayed by DNA microarray. The gene network around CLU and gene interactions were analyzed with the Ingenuity Pathway Analysis software. Downregulation of CLU resulted in modification of the expression of genes known to be directly linked to CLU and for almost 5% of the tested genes (857 out of 17,225); the upregulation of a small group of gene (e.g., TIAM1) emphasizes the hypothetical role of CLU in the pseudotumoral characteristic of FLS. The comparison of gene expression with or without TNF stimulation allowed the classification of sampled with good concordance. Moreover, differential comparison showed that CLU downregulation in RA led to a profound modification of the TNF-α response as three sets of genes emerged: 497 genes modulated by siCLU transfection with TNF stimulation, 356 genes modified because of TNF stimulation only, and 484 genes modulated during TNF stimulation with CLU expression (e.g., IL-8 and Wnt signaling genes). Using a global two-way ANOVA we could identify a set of genes defining a molecular signature of TNF response directly influenced by CLU. These results (based on differential gene expression patterns) argue that CLU downregulation in FLS alters their aggressiveness in RA synovitis.
- 31 July 2009
- Published by Elsevier in Joint Bone Spine
- Vol. 76 (4) , 327-332
Targeting lymphocyte activation to treat rheumatoid arthritis
- 31 July 2009
- Published by Elsevier in Joint Bone Spine
- Vol. 76 (4) , 327-332
Targeting lymphocyte activation to treat rheumatoid arthritis
- Open Access
- 13 January 2009
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 11 (1) , R5
No evidence of major effects in several Toll-like receptor gene polymorphisms in rheumatoid arthritis
Introduction: The objective was to study the potential genetic contribution of Toll-like receptor (TLR) genes in rheumatoid arthritis (RA). TLRs bind to pathogen-associated molecular patterns, and TLR genes influence both proinflammatory cytokine production and autoimmune responses. Host–pathogen interactions are involved in RA physiopathology. Methods: We tested SNPs of five TLR genes (TLR9, TLR2, TLR6, TLR1, and TLR4) in a cohort of 100 French families with RA. Genotypes were analyzed using the transmission disequilibrium test. As TLR2, TLR6, and TLR1 are located on chromosome 4, we determined the haplotype relative risk. Analyses were performed in subgroups defined by status for rheumatoid factor, anti-cyclic citrullinated peptide autoantibodies, and erosions. Results: We found no disequilibrium in allele transmission for any of the SNPs of the five TLR genes. In subgroup analyses, no associations were detected linking TLR9, TLR2, or TLR9/TLR2 to rheumatoid factor, anti-cyclic citrullinated peptide autoantibodies, or erosions. Haplotype analysis of the polymorphisms showed no haplotype associations in any of the subgroups. Conclusions: We found no evidence of major effects of TLR gene polymorphisms in RA, although we tested different TLR phenotypes. Moreover, no associations were noted with autoantibody production or erosions.
- 13 January 2009
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 11 (1) , R5
Open AccessNo evidence of major effects in several Toll-like receptor gene polymorphisms in rheumatoid arthritis
Introduction: The objective was to study the potential genetic contribution of Toll-like receptor (TLR) genes in rheumatoid arthritis (RA). TLRs bind to pathogen-associated molecular patterns, and TLR genes influence both proinflammatory cytokine production and autoimmune responses. Host–pathogen interactions are involved in RA physiopathology. Methods: We tested SNPs of five TLR genes (TLR9, TLR2, TLR6, TLR1, and TLR4) in a cohort of 100 French families with RA. Genotypes were analyzed using the transmission disequilibrium test. As TLR2, TLR6, and TLR1 are located on chromosome 4, we determined the haplotype relative risk. Analyses were performed in subgroups defined by status for rheumatoid factor, anti-cyclic citrullinated peptide autoantibodies, and erosions. Results: We found no disequilibrium in allele transmission for any of the SNPs of the five TLR genes. In subgroup analyses, no associations were detected linking TLR9, TLR2, or TLR9/TLR2 to rheumatoid factor, anti-cyclic citrullinated peptide autoantibodies, or erosions. Haplotype analysis of the polymorphisms showed no haplotype associations in any of the subgroups. Conclusions: We found no evidence of major effects of TLR gene polymorphisms in RA, although we tested different TLR phenotypes. Moreover, no associations were noted with autoantibody production or erosions.
- 8 December 2008
- Published by Wiley in Immunology
- Vol. 126 (1) , 35-44
Dendritic cells modulated by innate immunity improve collagen‐induced arthritis and induce regulatory T cells in vivo
Summary: Dendritic cells (DCs) mediate interactions between innate and specific immunity and may induce regulatory mechanisms. We investigated the effects of modulated DCs in mice with collagen‐induced arthritis (CIA) and tested the responses of cells to induced naturally occurring regulatory T cells. DCs were stimulated or not with DNA or lipopolysaccharide (LPS) for 24 hr. DC maturation was assayed, and then modulated DCs were intraperitoneally injected on day 14 into DBA/1 mice to treat CIA. In addition to arthritis scores and type 2 collagen (CII) response, the induction of CD4+ CD25+ T cells was analysed by flow cytometry in peripheral blood and the expression of Foxp3, transforming growth factor (TGF)‐β, interleukin (IL)‐10 and cytotoxic T‐lymphocyte antigen (CTLA)‐4 was quantified. Finally, the expression of indoleamine‐2,3‐dioxygenase (IDO) was assayed in DCs. In comparison with LPS‐stimulated DCs, plasmid‐stimulated DCs expressed lower levels of major histocompatibility complex (MHC) class II, CD40, CD80 and CD86 molecules and secreted less IL‐12p70, interferon (IFN)‐γ, IL‐10 and TNF‐α, displaying a semi‐mature phenotype. Compared with non‐stimulated DCs, stimulated DCs improved arthritis scores when injected after immunization, without modifying the T helper type 1 (Th1)/Th2 balance of the immune response against collagen. Stimulated DCs induced markers for regulatory T cells (Foxp3, TGF‐β1 and CTLA‐4) in vivo. Only LPS‐stimulated DCs expressed IDO, which may explain their better therapeutic efficacy. Regulatory mechanisms were induced using DCs modulated by innate immunity stimulators. Innate immunity mechanisms do not require the presence of the disease‐causing antigen, even in T‐ and B‐cell specific diseases. Our results have implications for the treatment of rheumatoid arthritis, an autoimmune disease whose triggering antigen has not been identified, and substantially clarify the role of regulatory T cells in CIA.
- 8 December 2008
- Published by Wiley in Immunology
- Vol. 126 (1) , 35-44
Dendritic cells modulated by innate immunity improve collagen‐induced arthritis and induce regulatory T cells in vivo
Summary: Dendritic cells (DCs) mediate interactions between innate and specific immunity and may induce regulatory mechanisms. We investigated the effects of modulated DCs in mice with collagen‐induced arthritis (CIA) and tested the responses of cells to induced naturally occurring regulatory T cells. DCs were stimulated or not with DNA or lipopolysaccharide (LPS) for 24 hr. DC maturation was assayed, and then modulated DCs were intraperitoneally injected on day 14 into DBA/1 mice to treat CIA. In addition to arthritis scores and type 2 collagen (CII) response, the induction of CD4+ CD25+ T cells was analysed by flow cytometry in peripheral blood and the expression of Foxp3, transforming growth factor (TGF)‐β, interleukin (IL)‐10 and cytotoxic T‐lymphocyte antigen (CTLA)‐4 was quantified. Finally, the expression of indoleamine‐2,3‐dioxygenase (IDO) was assayed in DCs. In comparison with LPS‐stimulated DCs, plasmid‐stimulated DCs expressed lower levels of major histocompatibility complex (MHC) class II, CD40, CD80 and CD86 molecules and secreted less IL‐12p70, interferon (IFN)‐γ, IL‐10 and TNF‐α, displaying a semi‐mature phenotype. Compared with non‐stimulated DCs, stimulated DCs improved arthritis scores when injected after immunization, without modifying the T helper type 1 (Th1)/Th2 balance of the immune response against collagen. Stimulated DCs induced markers for regulatory T cells (Foxp3, TGF‐β1 and CTLA‐4) in vivo. Only LPS‐stimulated DCs expressed IDO, which may explain their better therapeutic efficacy. Regulatory mechanisms were induced using DCs modulated by innate immunity stimulators. Innate immunity mechanisms do not require the presence of the disease‐causing antigen, even in T‐ and B‐cell specific diseases. Our results have implications for the treatment of rheumatoid arthritis, an autoimmune disease whose triggering antigen has not been identified, and substantially clarify the role of regulatory T cells in CIA.